Loading clinical trials...
Loading clinical trials...
The purpose of the study is to look at the effect a dietary supplement called CEAG \[Curcuminoids, EPA (Omega-3), Astaxanthin and Gamma Linolenic Acid (GLA)\] has on inflammation and endothelial (inne...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
NCT07550023 · Short Chain Fatty Acids Concentration in Stools, Gut Microbiota Diversity and Composition, and more
NCT07543666 · Inflammation, Obesity (Disorder)
NCT07547774 · Breast Cancer, Postoperative Pain, and more
NCT04888923 · Inflammation, Normal Controls, and more
NCT04810858 · Cannabis, HIV, and more
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Torrance, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions